· Preliminary EarningsMajor
Q3 operating profit KRW 49.2 billion, up 68.5% from a year earlier
GC Biopharma Corp.'s Q3 consolidated revenue was KRW 522.1 billion, down 14.3% on the year. Operating profit rose 68.5% on the year to KRW 49.2 billion.
GC Biopharma Corp. Disclosures
006280 · KOSPI · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from GC Biopharma Corp..